We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi and Others Score Victories at NICE, Ovarian Cancer Drugs Rebuked
Sanofi and Others Score Victories at NICE, Ovarian Cancer Drugs Rebuked
It has been a successful month in the UK for French drug giant Sanofi, with the National Institute for Health and Care Excellence backing two of its drugs.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor